Successfully advised Fullerton Healthcare Group on a complex workplace investigation involving alleged corruption and falsification of documents to defraud the company

Successfully advised Fullerton Healthcare Group, valued at S$1.5 billion in end 2022, on a complex workplace investigation against senior management, directors and founders of the company after the company received a whistle-blower alert. Partners Jonathan Yuen and Doreen Chia led the case.